MGMT and neoplasm: A study found that ill‐defined tumor borders, lower attenuation coefficients in computed tomography scans, lower fractional anisotropy, and increased apparent diffusion coefficient values are associated with MGMT promoter methylation in a mixed group of WHO grade III and grade IV patients [47].